Ovarian cancer is known for its aggressive spread, often targeting fatty tissues in the abdomen. Now, a study published in Nature Communications by researchers at Karolinska Institutet and Queen Mary University of London ...
Sep 30, 2025
0
46
Breast cancer remains the most common cancer and the leading cause of cancer-related death among women worldwide, with incidence rates continuing to rise. However, known risk factors, including genetics and lifestyle, do ...
Sep 22, 2025
0
0
The incidence of obesity-associated cancers in Puerto Rico rose significantly between 2000 and 2022, according to research presented at the 18th AACR Conference on the Science of Cancer Health Disparities, held September ...
Sep 19, 2025
0
0
Ovarian cancer is relatively rare. However, it's often fatal in later stages of the disease. The cancer begins in the ovaries and spreads to the abdomen and pelvis if it isn't diagnosed and treated early. It primarily affects ...
Sep 17, 2025
0
0
Researchers from Queen Mary University of London have developed and validated a new tool that could help GPs detect ovarian cancer earlier and improve patient outcomes cost-effectively.
Sep 17, 2025
0
0
A UNSW Sydney researcher says narrowing women's health to "bikini medicine"—issues that occur between the breasts and the pubic bone—has left women underserved in nearly every other area of health, including disease, ...
Sep 10, 2025
0
0
New research by Wistar Institute scientists shows how targeting a cleft in the retinoblastoma protein can kill tumor-protecting macrophages in ovarian cancer. The discovery provides a novel therapeutic target that could potentially ...
Sep 9, 2025
0
5
Research led by the Indiana University School of Medicine and the University of Florida reports an association between taking GLP-1 receptor agonists and lower overall cancer risk in adults with obesity or overweight, with ...
A new blood test pioneered by diagnostics company AOA Dx (AOA) can detect ovarian cancer in symptomatic women with high accuracy, a study by researchers from the Universities of Manchester and Colorado has found.
Aug 26, 2025
0
0
A preclinical evaluation of a new "dual-mode" tracer agent shows promise in not only helping surgeons image and plan prostate cancer procedures, but also provide them with much more consistent and targeted guidance during ...
Aug 21, 2025
0
2
